NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

Paxlovid’s role in treating COVID-19 is not ending — it is evolving, according to the results of two national trials ...

Add Yahoo as a preferred source to see more of our stories on Google. Joe Biden has COVID-19 again and is using Paxlovid, the Pfizer medication that has been widely used in the treatment of COVID ...

A recent patient-led case series highlights the potential benefits of extended courses of Pfizer Inc's (NYSE:PFE) Paxlovid (nirmatrelvir / ritonavir) for individuals with Long COVID. The study ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the latest ...

President Joe Biden announced he has COVID on Wednesday. The White House says his symptoms are mild, including a runny nose, cough, and malaise. He's taking the antiviral Paxlovid, but recent studies ...

CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...

Joe Biden has COVID-19 again and is using Paxlovid, the Pfizer medication that has been widely used in the treatment of COVID symptoms since 2021. The reassurance that the president, who is at ...